Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 30:6:1475132.
doi: 10.3389/frph.2024.1475132. eCollection 2024.

The evolutionary basis of elevated testosterone in women with polycystic ovary syndrome: an overview of systematic reviews of the evidence

Affiliations
Review

The evolutionary basis of elevated testosterone in women with polycystic ovary syndrome: an overview of systematic reviews of the evidence

Aiden Bushell et al. Front Reprod Health. .

Abstract

Polycystic ovary syndrome (PCOS) exhibits high prevalence and heritability despite causing negative impacts on fertility and fecundity. Previous hypotheses have postulated that some PCOS-associated traits, especially above-average levels of testosterone, were associated with benefits in ancestral environments. As such, PCOS would represent, in part, a maladaptive extreme of adaptations related to relatively high testosterone. To evaluate this hypothesis, we conducted a series of systematic literature reviews on the associations of testosterone levels, and prenatal testosterone metrics, with measures of strength, robustness, muscularity, and athleticism in females. We also systematically reviewed the literature on associations of testosterone with dominance in females and reviewed archaeological evidence concerning female strength and muscularity and its correlates. The main findings were fivefold: (1) elevated testosterone levels were generally associated with higher strength, muscularity and athleticism in females; (2) females with PCOS showed notable evidence of increased strength, muscularity, and athleticism compared to controls; (3) females with higher testosterone levels exhibited clear evidence of high dominance, (4) despite evidence that higher testosterone is linked with higher bone mineral density in healthy females, PCOS was not clearly associated with this phenotype; and (5) archaeological evidence from osteology, and data from some current small-scale societies, indicated that females often exhibit substantial levels of muscularity. Overall, the hypothesis that relatively high levels of testosterone are associated with benefits to females in some contexts was largely supported. These results provide evidence for the "maladaptive extremes of adaptation" model, with implications for treatment of females with PCOS and for future research.

Keywords: dominance; evolution; muscularity; polycystic ovary syndrome; strength; testosterone.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Comparison of the distributions of mean serum testosterone levels in women with PCOS, athletes, and controls, calculated from the data in Supplementary Table S2, Supplementary Table S4, and Supplementary Table S5.
Figure 2
Figure 2
Hypothesized ecological circumstances favoring (a) high testosterone in females, compared to (b) current environments promoting PCOS risk. The single-headed arrow represents hypothesized effects, while the double-headed arrow represents positive associations between traits.

Similar articles

Cited by

References

    1. McCartney CR, Marshall JC. Polycystic ovary syndrome. N Engl J Med. (2016) 375:54–64. 10.1056/NEJMcp1514916 - DOI - PMC - PubMed
    1. March W, Moore V, Willson K, Phillips DIW, Norman RJ, Davies MJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. (2010) 25:544–51. 10.1093/humrep/dep399 - DOI - PubMed
    1. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. (2014) 10:261–75. 10.1038/nrendo.2013.255 - DOI - PubMed
    1. Mykhalchenko K, Lizneva D, Trofimova T, Walker W, Suturina L, Diamond MP, et al. Genetics of polycystic ovary syndrome. Expert Rev Mol Diagn. (2017) 17:723–33. 10.1080/14737159.2017.1340833 - DOI - PubMed
    1. Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab. (2006) 91:2100–04. 10.1210/jc.2005-1494 - DOI - PubMed

LinkOut - more resources